<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04427462</url>
  </required_header>
  <id_info>
    <org_study_id>260376</org_study_id>
    <nct_id>NCT04427462</nct_id>
  </id_info>
  <brief_title>Mitochondria (MI) Energy - Linking Bioenergetic Phenotypes in Circulating Cells With Cardiometabolic Health in School-age Children</brief_title>
  <official_title>Linking Bioenergetic Phenotypes in Circulating Cells With Cardiometabolic Health in School-age Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arkansas Children's Hospital Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Arkansas Children's Hospital Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study is about how daily activities, behaviors, and fitness affect the health
      and function of blood cells and their mitochondria, which are the powerhouses of the cells.
      These small mitochondria inside the cells make energy, and are very important for the health
      of the body.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Determine the impact of physical activity and obesity status on circulating cells
      mitochondrial function (e.g., fat vs. carbohydrates combustion capacity, total oxidative
      capacity, mitochondrial number and proton leak).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2020</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">March 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Platelet mitochondrial respiration and its association with adiposity and peak aerobic capacity in children 8 to 10 years old.</measure>
    <time_frame>8 days</time_frame>
    <description>Platelet mitochondrial respiration from isolated platelets will be measured using a flux analyzer. Adiposity will be measured with dual X-ray absorptiometry, and peak aerobic capacity with an incremental cycle ergometer test. measure physical activity</description>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Healthy</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood, urine, saliva, and stool will be collected.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        8-10 year olds
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Ages 8-10 years Boys and girls All ethnicity All BMI

        Exclusion Criteria:

        severe persistent asthma exercise induced asthma autism spectrum disorder attention deficit
        hyperactivity disorder attention deficit disorder

          -  Opposition defiant disorder

          -  conduct disorder

          -  epilepsy

          -  chronic kidney disease

          -  hormonal disease

          -  autoimmune diseases

          -  bleeding disorders

          -  chronic infections

          -  mental health disorder

          -  Type 2 and Type 1 diabetes

          -  Other pre-existing medical conditions or medications as determined by the
             investigators to affect the outcomes of interest
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jill Gassaway, BS</last_name>
    <phone>501-364-3309</phone>
    <email>acncstudies@archildrens.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ashton Adkison, BS</last_name>
    <phone>501-364-3309</phone>
    <email>acncstudies@archildrens.org</email>
  </overall_contact_backup>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 10, 2020</study_first_submitted>
  <study_first_submitted_qc>June 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2020</study_first_posted>
  <last_update_submitted>June 10, 2020</last_update_submitted>
  <last_update_submitted_qc>June 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

